Exagen Inc. has announced conditional approval from the New York State Department of Health for its innovative new biomarker ...

A new study investigates the role of Krüppel-like factor 2 (KLF2, a protein coding gene involved in a variety of regulatory ...

Lupus affects different people in different ways, and skin problems like rashes or sores re common. In a new study, people ...

IGM Biosciences announced the discontinuation of imvotamab and IGM-2644 for autoimmune and inflammatory diseases, including ...

In the Phase 2b CARE study, the investigational drug, cenerimod, demonstrated safe and effective results for treatment of ...

In a new study published in Lupus Science & Medicine, researchers reviewed randomized clinical trials (RCTs) to assess ...

Having lupus can make everyday life challenging. When your lupus is active, symptoms like joint stiffness, pain, fatigue, confusion, or depression can make simple tasks difficult — and sometimes ...

In a new study, the drug, deucravacitinib, proved to be a safe and more effective treatment for cutaneous lupus erythematosus ...

Lupus doesn’t have one clear origin. Researchers believe it comes from a complex equation of factors. One part of the equation is your genetic makeup. Another part involves the hormones that regulate ...

The Lupus Foundation of America led the fight to secure lupus research funding through the Department of Defense’s (DoD) Congressionally Directed Medical Research Program (CDMRP). To date, our efforts ...

The scarcity of lupus-specific diet and nutrition information remains a great frustration. But research has given us insight into foods and lifestyle choices that can help diminish the harmful effects ...

Lupus is an unpredictable and misunderstood autoimmune disease. It is difficult to diagnose, hard to live with, and a challenge to treat. Lupus has a range of symptoms, and strikes without warning.